Penn Capital Management Company, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
Penn Capital Management Company, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,453,211
+20.5%
324,707
+13.3%
1.28%
+27.0%
Q2 2023$10,333,694
-6.3%
286,490
+0.3%
1.00%
-9.2%
Q1 2023$11,028,310
-32.6%
285,722
-0.3%
1.11%
-33.8%
Q4 2022$16,367,967
+30.6%
286,523
-9.2%
1.67%
+19.5%
Q3 2022$12,529,000
-5.0%
315,584
+5.3%
1.40%
-1.5%
Q2 2022$13,192,000
+58.2%
299,825
+33.3%
1.42%
+66.0%
Q1 2022$8,338,000
-26.5%
224,849
-19.5%
0.86%
-24.7%
Q4 2021$11,338,000
-4.0%
279,423
-3.8%
1.14%
-4.6%
Q3 2021$11,813,000
-6.1%
290,394
+4.9%
1.19%
-2.5%
Q2 2021$12,575,000
+12.2%
276,912
+3.0%
1.22%
+4.7%
Q1 2021$11,211,000
+8.7%
268,917
+11.4%
1.17%
-10.5%
Q4 2020$10,309,000
+32.8%
241,362
-17.5%
1.30%
+32.9%
Q3 2020$7,761,000
-1.0%
292,570
+0.9%
0.98%
-3.9%
Q2 2020$7,840,000
+53.2%
290,087
+2.1%
1.02%
+20.8%
Q1 2020$5,118,000284,1430.84%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders